A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321 (Q35058595)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321 |
scientific article |
Statements
1 reference
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321 (English)
1 reference
Alex A Adjei
1 reference
Julian R Molina
1 reference
Donald W Northfelt
1 reference
Yujie Zhao
1 reference
Nathan R Foster
1 reference
Jeffrey P Meyers
1 reference
Sachdev P Thomas
1 reference
Kendrith M Rowland
1 reference
Bassam I Mattar
1 reference
David B Johnson
1 reference
Sumithra J Mandrekar
1 reference
Steven E Schild
1 reference
James D Bearden
1 reference
Marie-Christine Aubry
1 reference
1 January 2015
1 reference
1 reference
10
1 reference
1
1 reference
172-180
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference